Mathew S. Maurer

Quick facts

Phase 2 pipeline

• Erythropoietin alpha · Oncology
  Erythropoietin alpha stimulates erythropoiesis by binding to the erythropoietin receptor.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Mathew S. Maurer portfolio CI brief
• Mathew S. Maurer pipeline updates RSS